SPONSOR
Novo Nordisk A/S
Total Trials
10
Recruiting
10
Phases
Phase 2, Phase 1, Phase 3
Conditions studied: Heart FailureObesityHealthy VolunteersDiabetes Mellitus, Type 2Transthyretin Amyloid Cardiomyopathy (ATTR CM)Myocardial InfarctionTransthyretin Amyloid CardiomyopathyKnee Osteoarthritis (OA)
Novo Nordisk A/S is a clinical research sponsor with 10 registered studies on ClinicalTrials.gov, of which 10 are actively recruiting participants. Research covers conditions including Heart Failure, Obesity, Healthy Volunteers, Diabetes Mellitus, Type 2.
The trial portfolio spans Phase 2, Phase 1, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Novo Nordisk A/S
How many clinical trials has Novo Nordisk A/S sponsored?
ClinicalMetric currently tracks 10 clinical trials sponsored by Novo Nordisk A/S, of which 10 are actively recruiting participants. These trials cover conditions including Heart Failure, Obesity, Healthy Volunteers. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Novo Nordisk A/S research focus on?
Novo Nordisk A/S clinical trials span Heart Failure, Obesity, Healthy Volunteers, Diabetes Mellitus, Type 2, Transthyretin Amyloid Cardiomyopathy (ATTR CM), and additional conditions. The research pipeline includes Phase 2, Phase 1, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Novo Nordisk A/S clinical trial?
To participate in a Novo Nordisk A/S trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Novo Nordisk A/S trials with current recruitment status updated daily.
Clinical Trials by Novo Nordisk A/S
NCT06979362 Phase 2
Recruiting
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
Heart Failure
NCT07225816 Phase 1
Recruiting
Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)
Obesity
NCT07508020 Phase 1
Recruiting
A Research Study Looking at How NNC0487-0111 Affects Food Intake, Appetite and Metabolism After Meals in People With Obesity
Obesity
NCT07570992 Phase 1
Recruiting
A Research Study to Evaluate the Safety of NNC1679-0001 When Given to Healthy Participants and Participants With T2DM
Healthy Volunteers
NCT07207811 Phase 3
Recruiting
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
NCT07301034 Phase 3
Recruiting
A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart, Compared to Placebo, in People With a Heart Attack
Myocardial Infarction
NCT07415954 Phase 2
Recruiting
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
Diabetes Mellitus, Type 2
NCT07448623 Phase 1
Recruiting
A Research Study to Look at the Distribution and Effects of Coramitug on Amyloid Deposits in Heart Tissue Using PET/CT Imaging in People With ATTR Amyloidosis.
Transthyretin Amyloid Cardiomyopathy
NCT07481630 Phase 3
Recruiting
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Obesity
NCT07527195 Phase 1
Recruiting
Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscle Health)
Obesity
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology